Targeting the Canonical Nuclear Factor-κB Pathway with a High-Potency IKK2 Inhibitor Improves Outcomes in a Mouse Model of Idiopathic Pneumonia Syndrome
- Resource Type
- Article
- Source
- In
Biology of Blood and Marrow Transplantation April 2017 23(4):569-580 - Subject
- Language
- ISSN
- 1083-8791